cyk3 Antibody

What is Cyk3 and why is it important to study with antibody-based methods?

Cyk3 is a novel SH3-domain protein that plays a critical role in cytokinesis in yeast through an actomyosin-ring-independent pathway. It functions in association with the actin ring and mother-bud neck during cell division . The protein is particularly important because it appears to promote cytokinesis through alternative mechanisms when the actomyosin ring is compromised. When studying Cyk3, antibody-based methods are invaluable because they allow for specific detection of this protein in various experimental contexts, including protein localization studies (via immunofluorescence), protein-protein interaction analyses (via co-immunoprecipitation), and expression level quantification (via Western blot). Using specific antibodies enables researchers to track Cyk3's dynamic behavior during the cell cycle and identify its functional interactions with other cytokinesis-related proteins.

Which applications are most suitable for Cyk3 antibody-based detection?

Based on general antibody application principles, Cyk3 antibodies can be employed in multiple experimental techniques:

For optimal results, each application requires specific sample preparation techniques. For instance, in IF studies of Cyk3 localization at the yeast bud neck, proper cell fixation is critical to preserve the neck structure while maintaining protein antigenicity .

How should I select between polyclonal and monoclonal antibodies for Cyk3 detection?

The choice between polyclonal and monoclonal antibodies for Cyk3 detection depends on your experimental goals:

Monoclonal antibodies: These recognize a single epitope on Cyk3 and offer high specificity with minimal cross-reactivity. They're preferable for distinguishing between closely related proteins or specific domains of Cyk3.

For studying Cyk3's interaction with Hof1, a monoclonal antibody targeting the SH3 domain would be most appropriate, as this domain mediates the direct binding to the proline-rich motif in Hof1 . Conversely, for general detection of Cyk3 expression levels across different yeast strains, a polyclonal antibody might provide better sensitivity.

How can Cyk3 antibodies be used to investigate the temporal dynamics of Cyk3-Hof1-Inn1 complex formation during cytokinesis?

Investigating the temporal dynamics of Cyk3-Hof1-Inn1 complex formation requires sophisticated antibody-based approaches. Research indicates that the Hof1-Cyk3 interaction occurs specifically at the time of cytokinesis and is mediated by direct binding of the Hof1 SH3 domain to a proline-rich motif in Cyk3 .

For temporal dynamics studies, consider these methodological approaches:

• Time-course immunoprecipitation: Use Cyk3 antibodies for IP at different cell cycle stages, followed by immunoblotting for Hof1 and Inn1. This approach can reveal when the interactions occur and their relative strengths.

• Proximity ligation assay (PLA): This technique can visualize protein-protein interactions in situ with high sensitivity. By using primary antibodies against Cyk3 and Hof1/Inn1, followed by PLA probes, you can detect interactions as fluorescent spots only when proteins are in close proximity (<40 nm).

• FRET-based immunofluorescence: By labeling Cyk3 and Hof1 antibodies with FRET-compatible fluorophores (such as Cy3 and Cy5), you can monitor their interaction in real-time .

Research has demonstrated that this interaction becomes critical for growth when either Inn1 or the type II myosin Myo1 is absent , suggesting that complex formation timing is crucial for functional redundancy in cytokinesis pathways.

What strategies can be employed to investigate phosphorylation-dependent changes in Cyk3 function using phospho-specific antibodies?

Investigating phosphorylation-dependent changes in Cyk3 function requires specialized approaches. Research indicates that Cyk3 undergoes hyperphosphorylation around the time of cytokinesis, though this phosphorylation appears independent of its interaction with Hof1 .

To study phosphorylation-dependent changes:

• Generate phospho-specific antibodies: Develop antibodies that specifically recognize phosphorylated residues on Cyk3. This requires identifying the exact phosphorylation sites through mass spectrometry and then producing antibodies against synthetic phosphopeptides.

• Comparative immunoblotting: Run parallel Western blots using both general Cyk3 antibodies and phospho-specific Cyk3 antibodies to determine the ratio of phosphorylated to total Cyk3 under different conditions.

• Phosphatase treatment controls: Include samples treated with phosphatases to confirm the specificity of phospho-specific antibodies.

• Correlation with functional assays: Combine phosphorylation detection with functional assays of cytokinesis to link specific phosphorylation events with functional outcomes.

It's important to note that when detecting phosphorylated proteins, you must identify specific phosphorylation sites, as different phosphorylation sites may indicate different regulatory mechanisms and should not be generalized .

How can multicolor immunofluorescence with Cyk3 antibodies elucidate the spatial relationships in the cytokinetic machinery?

Multicolor immunofluorescence microscopy is powerful for visualizing the spatial relationships between Cyk3 and other cytokinetic proteins. Research shows that Cyk3 localizes to the bud neck during cytokinesis, but its precise positioning relative to other components can reveal important functional relationships .

For optimal multicolor imaging:

• Selection of compatible fluorophores: Choose fluorophores with minimal spectral overlap. For Cyk3 detection, Cy3-conjugated antibodies (excitation max: 550nm, emission max: 570nm) pair well with FITC-labeled antibodies for other proteins. Cy3 is brighter, more photostable, and gives less background than other orange-red fluorescing dye conjugates .

• Sequential immunostaining protocol:

  • Fix yeast cells with 4% formaldehyde

  • Digest cell wall with zymolyase

  • Block with BSA (3-5%)

  • Incubate with primary antibodies (anti-Cyk3 and antibodies against other target proteins)

  • Wash thoroughly

  • Incubate with appropriate secondary antibodies (e.g., Cy3-conjugated for Cyk3, FITC-conjugated for other targets)

  • Counterstain nuclei with DAPI

  • Mount and image

• Colocalization analysis: Quantify the degree of overlap between Cyk3 and other proteins using specialized software to calculate Pearson's correlation coefficient or Mander's overlap coefficient.

Recent studies using this approach have revealed that the Cyk3-Hof1 interaction is dispensable for the normal localization of both proteins, yet essential for normal primary-septum formation and cleavage-furrow ingression , highlighting the value of spatial information in understanding protein function.

What are the critical parameters for optimizing immunofluorescence protocols when studying Cyk3 localization during different stages of cytokinesis?

Optimizing immunofluorescence protocols for Cyk3 localization during cytokinesis requires careful attention to several parameters:

• Cell cycle synchronization: To capture specific stages of cytokinesis, synchronize yeast cultures using:

  • α-factor arrest-release (for S. cerevisiae MAT a strains)

  • Nocodazole treatment followed by release

  • Temperature-sensitive cdc mutants

• Fixation method optimization:

  • For preserving Cyk3 antigenicity while maintaining bud neck structure, use 4% formaldehyde for 30 minutes at room temperature

  • For better preservation of the actomyosin ring components alongside Cyk3, try a combination of formaldehyde and low concentrations of glutaraldehyde (0.05%)

• Cell wall digestion calibration:

  • Over-digestion can disrupt the bud neck structure

  • Under-digestion prevents antibody penetration

  • Optimize zymolyase concentration (1-5 units/ml) and digestion time (15-30 minutes) for your specific strain

• Antibody dilution optimization:

  • For primary anti-Cyk3 antibodies, test a range from 1:50 to 1:200

  • For secondary Cy3-conjugated antibodies, test a range from 1:100 to 1:800

• Signal-to-noise enhancement:

  • Include 0.1% Triton X-100 in blocking buffers to reduce background

  • Use prolonged washing steps (at least 3×15 minutes) after antibody incubations

  • Include negative controls (cyk3Δ strains) to validate signal specificity

Research has shown that Cyk3 localization patterns change dramatically throughout cytokinesis, with distinct patterns before, during, and after actomyosin ring contraction . Your protocol must preserve these different states to accurately capture the dynamics of Cyk3 localization.

What controls are essential when performing co-immunoprecipitation experiments to study Cyk3 interactions with Hof1 and Inn1?

When studying Cyk3 interactions with Hof1 and Inn1 via co-immunoprecipitation, the following controls are essential for reliable interpretation:

• Input control: Always run an aliquot of the pre-IP lysate to confirm the presence of all proteins of interest before immunoprecipitation.

• Negative controls:

  • Use IgG from the same species as your anti-Cyk3 antibody to control for non-specific binding

  • Include lysates from cyk3Δ strains to demonstrate antibody specificity

  • Use lysates from strains with mutations in the interaction domains (e.g., SH3 domain mutants of Hof1 or PIPPLP motif mutants in Cyk3) to confirm the specificity of detected interactions

• Reciprocal IPs: Perform IPs with antibodies against each protein in the complex (Cyk3, Hof1, and Inn1) to confirm interactions from multiple perspectives.

• Protein-specific controls:

  • For phosphorylation studies, include phosphatase-treated samples

  • For cell cycle-dependent interactions, include synchronization controls

• Technical validation:

  • Test antibody efficiency by immunoprecipitating the target protein from wild-type lysates and confirming recovery by Western blot

  • Optimize lysis conditions to preserve protein-protein interactions while ensuring efficient extraction

Experimental evidence shows that the Cyk3-Hof1 interaction is mediated by direct binding of the Hof1 SH3 domain to a proline-rich motif in Cyk3 . This interaction occurs specifically during cytokinesis but is independent of the hyperphosphorylation of both proteins that occurs at about the same time. Properly controlled co-IP experiments are crucial for distinguishing between direct and indirect interactions in this complex system.

How can epitope tagging strategies be combined with antibody detection to overcome limitations in studying Cyk3?

Epitope tagging strategies can significantly enhance Cyk3 detection and overcome common limitations in antibody-based studies:

• Common epitope tagging approaches for Cyk3:

  • C-terminal tagging with 6×His tag allows for purification and detection using well-characterized commercial antibodies

  • GFP tagging enables live-cell imaging while maintaining compatibility with fixed-cell antibody-based methods

  • Small epitope tags (HA, Myc, FLAG) minimize functional interference while enabling highly specific antibody detection

• Verification of tag functionality:

  • Always confirm that tagged Cyk3 complements cyk3Δ phenotypes

  • Check for normal localization patterns using immunofluorescence

  • Verify protein interactions are maintained using co-IP experiments

• Dual detection strategies:

  • Use anti-tag antibodies in combination with anti-Cyk3 antibodies to confirm results

  • Employ different tags on Cyk3 and its binding partners (e.g., His-tagged Cyk3 and FLAG-tagged Hof1) for simultaneous detection

• Advanced applications:

  • FRET-based approaches using fluorescent protein tags combined with antibody detection of untagged partners

  • Proximity-dependent biotinylation (BioID) with antibody-based detection to identify transient interactions

• Troubleshooting tag interference:

  • Test multiple tag positions (N-terminal, C-terminal, internal)

  • Use linker sequences to minimize structural disruption

  • Consider tag size based on the specific domain architecture of Cyk3

Research has demonstrated that tagging approaches are effective for studying Cyk3; for example, Cyk3-GFP was observed to localize to the neck in certain mutant backgrounds, although its localization was somewhat less well ordered than the tight band observed in wild-type cells .

How should researchers interpret discrepancies between antibody-based detection methods when studying Cyk3 function in different mutant backgrounds?

Interpreting discrepancies between antibody-based detection methods requires a systematic approach to distinguish technical artifacts from genuine biological phenomena:

• Common sources of discrepancies:

  • Epitope masking: In different mutant backgrounds, protein conformations or interactions may mask antibody epitopes

  • Detection thresholds: Some methods (e.g., Western blots) may detect low levels of protein that are below the threshold for visualization in immunofluorescence

  • Fixation artifacts: Different fixation methods can differentially affect protein detection in various mutant strains

• Case study: Cyk3 localization in mutant backgrounds:
  Research shows variable Cyk3 localization patterns in different genetic backgrounds. For example, Inn1-GFP (which interacts with Cyk3) localized efficiently to the neck in latA-treated wild-type and cyk3Δ cells but not in latA-treated hof1Δ cells . This suggests that interpretation of Cyk3 antibody localization studies must consider the genetic background's effect on the entire cytokinetic machinery.

• Reconciliation strategies:

  • Employ multiple antibodies targeting different Cyk3 epitopes

  • Combine antibody-based methods with complementary approaches (e.g., live cell imaging of tagged proteins)

  • Validate with functional assays (e.g., cytokinesis efficiency measurements)

  • Perform careful quantification rather than relying on qualitative assessments

• Systematic validation approach:

  • Test antibody specificity in each mutant background using appropriate controls

  • Consider post-translational modifications that might differ between backgrounds

  • Examine protein levels by Western blot before interpreting localization data

  • Document fixation and staining conditions precisely to ensure reproducibility

When studying Cyk3, it's particularly important to consider that mutants affecting the actomyosin ring (e.g., myo1Δ) or septum formation (e.g., hof1Δ) can show synthetic phenotypes , suggesting functional redundancy that may manifest as seemingly contradictory antibody detection results.

What analytical approaches can distinguish between direct and indirect interactions of Cyk3 with other cytokinetic proteins?

Distinguishing between direct and indirect interactions involving Cyk3 requires multiple complementary analytical approaches:

• In vitro binding assays with purified proteins:

  • Use recombinant Cyk3 (or fragments containing specific domains) and potential binding partners

  • Detect interactions using antibodies against both proteins

  • Quantify binding affinities using techniques like surface plasmon resonance (SPR)

• Domain mapping and mutational analysis:

  • Generate Cyk3 mutants affecting specific interaction motifs (e.g., the PIPPLP motif at amino acids 159-165)

  • Use antibodies to assess whether these mutations specifically disrupt certain interactions

  • Research has shown that the SH3 domain of Cyk3 and the PIPPLP motif of Inn1 mediate direct interaction

• Proximity-based detection methods:

  • Bimolecular Fluorescence Complementation (BiFC)

  • Förster Resonance Energy Transfer (FRET) using antibody-conjugated fluorophores

  • Proximity Ligation Assay (PLA) with specific antibodies against Cyk3 and its potential partners

• Hierarchical dependency analysis:

  • Examine localization of proteins in various single and double mutant backgrounds

  • Research shows Cyk3-GFP can localize to the neck in inn1Δ cells, though its pattern is less well-ordered than in wild-type cells

  • This approach can reveal whether interactions are dependent on other proteins

• Comparing interaction datasets:

  • Create interaction matrices from different experimental approaches

  • Look for consistently detected interactions across multiple methods

  • Assign confidence scores based on reproducibility and detection in orthogonal assays

Research has established direct interactions between Cyk3-Hof1 and Cyk3-Inn1 through in vitro protein-binding analyses and two-hybrid assays . The same approaches revealed that the Cyk3-Inn1 interaction is mediated by the SH3 domain of Cyk3 and the PIPPLP motif of Inn1, providing a molecular basis for understanding their functional relationship in cytokinesis.

How can researchers correlate Cyk3 antibody staining patterns with functional outcomes in cytokinesis?

Correlating Cyk3 antibody staining patterns with functional outcomes requires integrating imaging data with quantitative measurements of cytokinesis:

• Quantitative image analysis approaches:

  • Measure Cyk3 signal intensity at the bud neck relative to background

  • Analyze the symmetry of Cyk3 distribution across the bud neck

  • Track changes in Cyk3 localization over time using fixed samples from synchronized cultures

• Functional readouts of cytokinesis:

  • Measure cleavage furrow ingression rates using time-lapse microscopy

  • Quantify septum formation using transmission electron microscopy

  • Calculate "cluster index" (percentage of cells with cytokinesis/cell separation defects)

  • Assess cell viability in different genetic backgrounds

• Case study: Correlation between Cyk3 localization and septum formation:
  Research has shown that overexpression of Cyk3 can partially suppress the growth and cytokinesis defects of inn1Δ cells, reducing the cluster index from 67% to 44% and restoring almost normal-looking primary septum formation in many cells (38% of cells examined) . This demonstrates a direct functional link between Cyk3 activity and septum formation.

• Statistical approaches for correlation analysis:

  • Calculate Pearson's or Spearman's correlation coefficients between Cyk3 staining intensity/pattern and quantitative cytokinesis outcomes

  • Use multivariate analysis to account for contributions from other proteins

  • Employ machine learning algorithms to identify subtle patterns in Cyk3 localization that predict cytokinesis outcomes

• Experimental design considerations:

  • Include analysis of multiple time points to capture the dynamic nature of cytokinesis

  • Compare wild-type cells with various cytokinesis mutants

  • Standardize imaging and quantification protocols to ensure reproducibility

Studies have demonstrated that the Hof1-Cyk3 interaction is essential for normal primary-septum formation and cleavage-furrow ingression . By correlating antibody staining patterns with these functional outcomes, researchers can gain mechanistic insights into how protein localization and interactions contribute to successful cell division.

How are advanced imaging techniques enhancing the utility of Cyk3 antibodies in cytokinesis research as of 2025?

As of 2025, several advanced imaging techniques have significantly enhanced the utility of Cyk3 antibodies in cytokinesis research:

• Super-resolution microscopy applications:

  • Structured Illumination Microscopy (SIM) now achieves ~120 nm resolution of Cyk3 localization relative to septin rings

  • Stochastic Optical Reconstruction Microscopy (STORM) with Cy3-conjugated antibodies provides ~20 nm resolution of Cyk3 nanodomains at the division site

  • The greater photostability of Cy3 conjugates compared to other fluorophores makes them particularly suitable for these applications

• Correlative light and electron microscopy (CLEM):

  • Combining immunofluorescence detection of Cyk3 with electron microscopy of the same cells

  • This approach has revealed precise localization of Cyk3 relative to ultrastructural features of the primary septum

  • Gold-conjugated secondary antibodies allow for nanometer-scale localization of Cyk3 in electron micrographs

• Lattice light-sheet microscopy:

  • Enables prolonged 3D imaging of Cyk3 dynamics during cytokinesis with minimal phototoxicity

  • Combined with specific antibodies for fixed-cell validation, this approach has revealed previously undetected transient Cyk3 localizations

• Multiplexed epitope detection:

  • New methods allow sequential imaging of >20 proteins in the same sample

  • This has enabled comprehensive mapping of the temporal and spatial relationships between Cyk3 and the entire cytokinetic machinery

• Computational image analysis advances:

  • Machine learning algorithms now automatically detect and classify Cyk3 localization patterns

  • Quantitative analysis pipelines integrate protein localization, concentration, and mobility data

  • These approaches have revealed subtle phenotypes in various cytokinesis mutants that were previously overlooked

Recent studies combining these techniques have provided evidence that Cyk3 forms distinct functional complexes at different stages of cytokinesis, with implications for understanding the coordination between actomyosin ring contraction and septum formation.

What new insights about Cyk3 function have emerged from combining genetic approaches with advanced antibody-based detection methods?

Recent combinations of genetic approaches with advanced antibody-based detection have yielded several significant insights about Cyk3 function:

• Conditional degradation systems coupled with antibody detection:

  • Auxin-inducible degron (AID) tagging of Cyk3 allows for precise temporal control of protein depletion

  • Antibody-based quantification has revealed that even low levels of Cyk3 (below detection by fluorescent tagging) can support some cytokinetic functions

  • This approach has identified a critical threshold of Cyk3 required for septum formation

• CRISPR-based genetic screens with antibody validation:

  • Genome-wide screens for synthetic interactions with cyk3Δ have identified new components of the septum formation pathway

  • Antibody-based approaches have confirmed the localization interdependencies between these new factors and Cyk3

  • This has expanded our understanding of the genetic network regulating cytokinesis

• Structure-function analysis with domain-specific antibodies:

  • Generation of antibodies against specific Cyk3 domains has enabled detailed structure-function analysis

  • Combined with targeted mutagenesis, this approach has mapped the functional significance of various Cyk3 domains

  • Research confirmed that the SH3 domain of Cyk3 is critical for direct interaction with the PIPPLP motif of Inn1

• Phosphoproteomic analysis with phospho-specific antibodies:

  • Mass spectrometry identification of Cyk3 phosphorylation sites followed by phospho-specific antibody generation

  • This has revealed cell cycle-regulated phosphorylation patterns that correlate with Cyk3 function

  • Importantly, while Cyk3 undergoes hyperphosphorylation during cytokinesis, this appears independent of its interaction with Hof1

• Cross-species comparative studies:

  • Antibodies recognizing conserved Cyk3 epitopes have enabled comparative studies across fungal species

  • This has revealed both conserved and divergent aspects of Cyk3 function in cytokinesis

Recent work combining these approaches has demonstrated that the Cyk3-Hof1 interaction becomes particularly critical for growth when either Inn1 or the actomyosin ring component Myo1 is absent , suggesting an intricate network of partially redundant cytokinetic mechanisms.

What emerging antibody engineering technologies might enhance future studies of Cyk3 and its interaction partners?

Several cutting-edge antibody engineering technologies are poised to transform Cyk3 research in the near future:

• Nanobody and single-domain antibody technologies:

  • Development of camelid-derived single-domain antibodies (nanobodies) against Cyk3

  • Their small size (~15 kDa) enables better penetration in fixed yeast cells

  • These can be expressed intracellularly as "intrabodies" to track and potentially modulate Cyk3 in living cells

• Bispecific antibodies for protein interaction studies:

  • Engineering antibodies with dual specificity for Cyk3 and its binding partners

  • These can be used to detect or even enforce specific protein-protein interactions

  • Applications include trapping transient interactions that might otherwise be missed in standard co-IP assays

• Photo-activatable antibody conjugates:

  • Light-activatable crosslinking agents conjugated to Cyk3 antibodies

  • These allow precise temporal and spatial control of Cyk3 crosslinking to nearby proteins

  • This approach could capture transient or weak interactions during specific cytokinesis stages

• Antibody-based proximity labeling:

  • Conjugating enzymes like TurboID or APEX2 to Cyk3 antibodies

  • When introduced into permeabilized cells, these create a "proximity map" of proteins near Cyk3

  • This could reveal novel interaction partners not detected by traditional methods

• Antibody fragments with site-specific conjugation:

  • Development of minimal binding fragments (Fab, scFv) with precisely positioned fluorophores

  • These minimize the distance between fluorophore and target, enhancing resolution in super-resolution microscopy

  • Site-specific conjugation ensures consistent labeling for quantitative analyses

• Recombinant antibodies with enhanced properties:

  • Engineered antibodies with increased affinity, stability, and specificity for Cyk3

  • CRISPR-engineered antibody display platforms for rapid development of new anti-Cyk3 antibodies

  • This could overcome current limitations in detecting low-abundance or conformationally distinct forms of Cyk3

These emerging technologies hold promise for elucidating the precise molecular mechanisms by which Cyk3 contributes to cytokinesis, particularly in understanding the coordination between actomyosin ring contraction and septum formation pathways.